EP1861169
Use of 13,14-dihydro-15-keto-16,16-difluoro prostaglandin E1 or 13,14-dihydro-15-keto-16,16-difluoro-18-methyl prostaglandin E1 for the treatment of cancer
:
EP einkaleyfi: Þýðing ekki lögð inn:
22.3.2006:
11.5.2016:
06730328.9
:
21.3.2026
:
Use of 13,14-dihydro-15-keto-16,16-difluoro prostaglandin E1 or 13,14-dihydro-15-keto-16,16-difluoro-18-methyl prostaglandin E1 for the treatment of cancer
22.3.2006
11.5.2016
:
Sucampo AG:
Baarerstrasse 22, 6300, Zug, CH
:
NORTH CAROLINA STATE UNIVERSITY:
4700 Hillsborough Street, 27606, Raleigh, NC, US
:
UENO, Ryuji:
Maryland, US
:
KUNO, Sachiko:
Maryland, US
:
BLIKSLAGER, Anthony, T.:
Apex, NC, US
:
MOESER, Adam, J.:
Raleigh, NC, US
:
663200 P:
21.3.2005:
US
:
679920 P:
11.5.2005:
US
:
721976 P:
30.9.2005:
US
:
JP2006306380:
22.3.2006
:
A61P 1/04, A61P 35/00, A61K 31/557, C07C 405/00